4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-22-034759
CEO sold 50,000 shares at an average $46.33 ($2,316,428)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2022-10-31 | Sale | −7,567 | $44.92 | $339,944 | 1,080,953 | D |
| Evans John M. CEO | 2022-10-31 | Sale | −7,768 | $46.19 | $358,819 | 1,073,185 | D |
| Evans John M. CEO | 2022-10-31 | Sale | −11,756 | $46.88 | $551,137 | 1,061,429 | D |
| Evans John M. CEO | 2022-10-31 | Sale | −2,909 | $47.89 | $139,325 | 1,058,520 | D |
| Evans John M. CEO | 2022-10-31 | Sale | −5,008 | $44.93 | $224,993 | 117,992 | I |
| Evans John M. CEO | 2022-10-31 | Sale | −4,569 | $46.19 | $211,034 | 113,423 | I |
| Evans John M. CEO | 2022-10-31 | Sale | −8,235 | $46.91 | $386,339 | 105,188 | I |
| Evans John M. CEO | 2022-10-31 | Sale | −2,188 | $47.91 | $104,836 | 103,000 | I |
| Open-market sales · 50,000 sh · avg $46.33 · $2,316,428 | |||||||
Loading xslF345X03/doc4.xml…